(Q43708959)

English

Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil

scientific article published on 21 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Pseudomonas aeruginosa

0 references

0 references

Carlos Magno Castelo Branco Fortaleza

0 references

author name string

Carlos Magno C B Fortaleza

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Maristela P Freire

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Djalma de C Moreira Filho

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Marcelo de Carvalho Ramos

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

21 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

901-906

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Epidemiological study of variations in beta-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Antimicrobial use and antimicrobial resistance: a population perspective

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli.

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns

1 reference

https://api.crossref.org/works/10.1086%2F507288

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43708959&oldid=2102731508"